Great to see in @JCOOP_ASCO - Mayo experience with outpt teclistamab step-up dosing in #MMsm.
This is where the field is headed, and impressive to see how quickly @MayoMyeloma campuses moved there - and how much this ⬇️ time toxicity for patients!
https://t.co/iSquYNCsqN
HOPA Members @Pharmer_Mike_@SandahlTyler@RachelBubik recently contributed to this late-breaking news article, showing how CAR-T Cell treatment is moving up the rung in Multiple Myeloma and breaking ground in Chronic Lymphocytic Leukemia: https://t.co/qOykl1HE7m
Compared with historic controls, omission of premedications after daratumumab cycle 1 did not increase incidence of infusion reactions compared with those who received premeds; as a result, de-escalation may be considered. ➡️ https://t.co/rjsEMv4xSo @SandahlTyler#mmsm
Beautiful and heartbreaking. Thank you @KB_McCullough for bearing your soul for us and putting words to a feeling many of us know so well but can’t quite describe. ❤️❤️❤️
Glad to have had the opportunity to present on a topic near and dear to my heart with @kczmj@katmapes and @PharmacyTimesCE ! Very proud to have had such great turnout!
#HOPAAC23 @MayoMyeloma
We are celebrating Bob Kyle’s 95th Birthday today. @MayoClinic @MayoMyeloma
@MayoCancerCare
Picture taken today at The Foundation House at Mayo Clinic.
1/
With her strong and poignant words, @TheAmandaGorman reminds us of the power we each hold in upholding our democracy. Keep shining, Amanda! I can't wait to see what you do next. 💕 #BlackGirlMagic
Photo credit: Rob Carr